Enoxaparin Sodium Injection, Solution
Product Images NDC 72603-215

Product Visual Gallery

This gallery contains 45 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 72603-215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg Blister (100mg Blister)

Labels for Enoxaparin Sodium Injection, USP 100 mg/mL by NorthStar Rx LLC. Each label shows product name, strength, dosage form, NDC 72603-205-01, and barcodes. The labels include detailed text with usage instructions and storage information for this prescription subcutaneous injection solution.*

FDA Label Image

100mg Carton (100mg Carton)

Packaging label for Enoxaparin Sodium Injection, USP, 100 mg per 1 mL dosage in a ten 1 mL single-dose syringes with automatic safety device. The label indicates subcutaneous use and is produced by NorthStar Rx LLC with manufacturing by Shenzhen Techdow Pharmaceutical Co., Ltd. The product is branded as Aisling and features storage and dosage instructions alongside barcodes.*

FDA Label Image

100mg Syringe (100mg Syringe)

Label for Enoxaparin Sodium Injection, USP 100 mg/mL solution for subcutaneous injection. The label includes the NDC 72603-205-01 and states it is manufactured in China for Northstar Rx LLC. It has designated areas for lot number and expiration date.*

FDA Label Image

120mg Blister (120mg Blister)

The image shows multiple peel-off labels for Enoxaparin Sodium injection, USP 120 mg/0.8 mL by NorthStar RxLLC. Each label features the product name, strength, dosage form as an injection solution, and a barcode. The labels include administration instructions and storage information, emphasizing subcutaneous use. The NDC number 72603-215-01 is printed on each label.*

FDA Label Image

120mg Carton (120mg Carton)

Packaging label for Enoxaparin Sodium Injection, USP 120 mg/0.8 mL subcutaneous injection. The label indicates ten 0.8 mL single-dose syringes with automatic safety device. The product is manufactured for NorthStar Rx LLC and displays the brand name Aisling. The label includes dosage and administration information, storage instructions, and warnings.*

FDA Label Image

120mg Syringe (120mg Syringe)

Label for Enoxaparin Sodium Injection, USP 120 mg/0.8 mL, a subcutaneous injection solution by Northstar Rx LLC. The label includes the NDC number 72603-215-01, states it is manufactured in China, and has space for lot and expiration dates. The label features a purple and white color scheme with barcodes on two sides.*

FDA Label Image

150mg Blister (150mg Blister)

Label sheet for Enoxaparin Sodium 150 mg/mL injection, solution, subcutaneous, produced by NorthStar RxLLC. Each label includes the proprietary name, strength 150 mg/1 mL, and product identifiers including NDC 72603-225-01. The label indicates Rx only status and provides storage and usage instructions. Multiple identical labels are arranged on the sheet with barcodes and peel tabs for application.*

FDA Label Image

150mg Carton (150mg Carton)

Packaging label for Enoxaparin Sodium Injection, USP, 150 mg/1 mL in 1 mL single-dose syringes with automatic safety device. The carton contains ten syringes for subcutaneous use. Labeler is NorthStar Rx LLC with manufacturing by Shenzhen Techdow Pharmaceutical Co., Ltd. The brand name Aisling appears on the packaging.*

FDA Label Image

150mg Syringe (150mg Syringe)

Label for Enoxaparin Sodium Injection, USP 150 mg/1 mL solution for subcutaneous injection. The label includes the NDC 72603-225-01, indicates Rx only, and states the product is manufactured in China for NorthStar Rx LLC. Lot and expiration date fields are present but not filled in.*

FDA Label Image

30mg Blister (30mg Blister)

Enoxaparin Sodium 30 mg/0.3 mL injection solution subcutaneous label by NorthStar RxLLC. The label includes product name, strength, dosing information, barcodes, and manufacturer details. Multiple identical labels are shown on a single sheet with instructions to peel off each label.*

FDA Label Image

30mg Carton (30mg Carton)

Packaging label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL by NorthStar Rx LLC. The label indicates ten 0.3 mL single-dose syringes with an automatic safety device for subcutaneous use. The box design includes white, blue, and green colors with dosage and manufacturer information, including Shenzhen Techdow Pharmaceutical Co., Ltd. The brand name Aisling appears on the label.*

FDA Label Image

Syringe (30mg Syringe)

Label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL solution for subcutaneous injection. The label includes the NDC 72603-165-01, indicates it is Rx only, and states it is manufactured in China for NorthStar Rx LLC. There are spaces for lot and expiration dates, and the label features barcodes on the left and right sides.*

FDA Label Image

40mg Blister (40mg Blister)

This image displays multiple peelable labels for Enoxaparin Sodium Injection, USP 40 mg/0.4 mL subcutaneous injection by NorthStar RxLLC. Each label includes the proprietary name, strength, dosage form, administration instructions, lot number, expiry, barcodes, and handling warnings, arranged in rows and columns on a white background.*

FDA Label Image

40mg Carton (40mg Carton)

Packaging label for Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL solution for subcutaneous use. The label indicates ten 0.4 mL single-dose syringes with an automatic safety device. Manufactured for NorthStar Rx LLC by Shenzhen Techdow Pharmaceutical Co., Ltd. The label features yellow, green, and white colors with the brand name Aisling® prominently displayed.*

FDA Label Image

40mg Syringe (40mg Syringe)

Label for Enoxaparin Sodium Injection, USP 40 mg/0.4 mL, a subcutaneous injection manufactured in China for NorthStar Rx LLC. The label includes the NDC 72603-175-01 barcode, designation as Rx only, and spaces for lot and expiration date information.*

FDA Label Image

60mg Blister (60mg Blister)

Label sheet of Enoxaparin Sodium 60 mg/0.6 mL subcutaneous injection solution by NorthStar RxLLC. The labels include the proprietary name, strength, dosage form, NDC number 72603-185-01, and usage instructions. Each label has barcodes and warnings about Rx only use, with peel-off sections indicated.*

FDA Label Image

60mg Carton (60mg Carton)

Packaging label for Enoxaparin Sodium injection, USP, 60 mg/0.6 mL solution in single-dose syringes for subcutaneous use. The label indicates the product includes ten 0.6 mL single-dose syringes with automatic safety devices. The labeler is NorthStar Rx LLC and the product is manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd. The branding includes the name Aisling and states prescription use only.*

FDA Label Image

60mg Syringe (60mg Syringe)

Label for Enoxaparin Sodium injection, USP, with strength 60 mg/0.6 mL. The label indicates subcutaneous injection, manufacture in China for Northstar Rx LLC, and includes space for lot and expiration dates. The design features an orange and white color scheme with black text and barcodes.*

FDA Label Image

80mg Blister (80mg Blister)

Labels for Enoxaparin Sodium 80 mg/0.8 mL solution for subcutaneous injection. Each label shows the drug name, strength, and dosage form with red and black text on a white background. The label includes barcodes and manufacturer information for NorthStar RxLLC, along with usage instructions and statutory details.*

FDA Label Image

80mg Carton (80mg Carton)

Carton packaging label for Enoxaparin Sodium Injection, USP by NorthStar Rx LLC. The label shows an 80 mg/0.8 mL single-dose syringe strength for subcutaneous use. It indicates the product contains ten 0.8 mL single-dose syringes with an automatic safety device. The label includes storage instructions and manufacturer details for Shenzhen Techdow Pharmaceutical Co., Ltd.*

FDA Label Image

80mg Syringe (80mg Syringe)

Label for Enoxaparin Sodium Injection, USP 80 mg/0.8 mL solution for subcutaneous injection. The label shows the National Drug Code (NDC) 72603-195-01 and indicates the product is manufactured in China for NorthStar Rx LLC. It includes space for lot number and expiration date and features barcodes on the left and right sides.*

FDA Label Image

Enoxaparin-fig6 (Enoxaparin Fig6)

A forest plot chart comparing relative risk between Unfractionated Heparin (UFH) and Enoxaparin Sodium (Enox) across multiple patient subgroups. The horizontal axis shows relative risk with markers indicating which treatment is better. Subgroups include sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent type, time to treatment, and PCI status, with numerical values for percentage risk under both treatments and risk reduction percentages.*

FDA Label Image

Enoxaparin-fig7 (Enoxaparin Fig7)

A survival analysis chart showing the hazard distribution function over time (days) to death or myocardial re-infarction for Enoxaparin Sodium and Unfractionated Heparin (UFH). The graph includes a smaller inset graph depicting hazard over one year, with noted p-values for log-rank tests indicating statistical comparisons between treatments. A risk table under the main graph shows numbers of patients at risk at various time points for both groups.*

FDA Label Image

Enoxaparin-str1 (Enoxaparin Str1)

Chemical structure diagram of Enoxaparin Sodium, showing its repeating polysaccharide units with sodium carboxylate (COONa) and sulfate groups as indicated by R1 and R2 substituents.*

FDA Label Image

Enoxaparin-str2 (Enoxaparin Str2)

Chemical structure diagram of Enoxaparin Sodium, showing its molecular components and bonds in a two-dimensional format.*

FDA Label Image

Figure-a (Figure A)

An instructional line drawing labeled Figure A shows two hands holding a syringe with a removable cap. The illustration demonstrates removing the cap from the syringe, indicated by double arrows pointing away from each other between the cap and syringe tip.*

FDA Label Image

Figure-b (Figure B)

An instructional line drawing labeled Figure B showing a hand administering a subcutaneous injection with a syringe into the skin of another person's arm or side. An arrow indicates the direction of needle insertion into the skin fold.*

FDA Label Image

Figure-c (Figure C)

An instructional line drawing labeled Figure C showing a hand holding a syringe-like device administering a subcutaneous injection into the skin, indicated by an arrow pointing toward the skin surface.*

FDA Label Image

Figure-d (Figure D)

An instructional line drawing labeled Figure D shows a hand holding a prefilled syringe with the thumb pressing a plunger, demonstrating proper technique for administering a subcutaneous injection using the Enoxaparin Sodium injection solution.*

FDA Label Image

Figure-e (Figure E)

An instructional diagram showing a gloved hand disposing of a syringe into a biohazard sharps container, illustrating safe disposal of injection equipment.*

FDA Label Image

Instruction-for-us-figure-a (Instruction For Us Figure A)

An instructional diagram showing the components for administering Enoxaparin Sodium injection. It includes a Lovenox prefilled syringe, a cotton ball or gauze, a sharps disposal container, an alcohol wipe, and a small adhesive bandage, each labeled to indicate their use in the subcutaneous injection process.*

FDA Label Image

Instruction-for-us-figure-b (Instruction For Us Figure B)

An instructional illustration showing hands removing a protective adhesive backing from a medical device, likely a prefilled syringe or injection device, as part of preparation for use.*

FDA Label Image

Instruction-for-us-figure-c (Instruction For Us Figure C)

The image shows a black and white illustration of a prefilled syringe for Enoxaparin Sodium injection solution. The syringe includes volume markings and a label area indicating the expiration date. It is designed for subcutaneous administration. The labeler is NorthStar RxLLC.*

FDA Label Image

Instruction-for-us-figure-d (Instruction For Us Figure D)

Illustration of a prefilled syringe for Enoxaparin Sodium injection. The syringe contains a clear liquid solution and displays a detailed view of the syringe barrel, plunger, and needle assembly for subcutaneous administration.*

FDA Label Image

Instruction-for-us-figure-e (Instruction For Us Figure E)

An instructional diagram illustrating the injection sites for Enoxaparin Sodium solution administered subcutaneously. It shows the lower abdominal area with two shaded rectangular zones on either side of the navel, indicating recommended areas for subcutaneous injection.*

FDA Label Image

Instruction-for-us-figure-f (Instruction For Us Figure F)

Instructional illustration showing a hand wiping the skin on the abdomen with a wipe, likely as a step before administering a subcutaneous injection of enoxaparin sodium.*

FDA Label Image

Instruction-for-us-figure-g (Instruction For Us Figure G)

An instructional illustration showing hands preparing a syringe with a cap being removed or placed on the needle. The diagram is likely part of administration or preparation instructions for an injection, relevant for subcutaneous use.*

FDA Label Image

Instruction-for-us-figure-h (Instruction For Us Figure H)

An instructional diagram showing a hand holding a syringe for Enoxaparin Sodium injection solution. The image includes an arrow pointing downward and a dashed line labeled "Set your dose," indicating how to adjust the syringe plunger to the correct dosage for subcutaneous administration.*

FDA Label Image

Instruction-for-us-figure-i (Instruction For Us Figure I)

An instructional illustration showing a person administering a subcutaneous injection in the abdominal area. The image focuses on the hand holding the syringe and the injection site near the navel, demonstrating proper technique for Enoxaparin Sodium injection.*

FDA Label Image

Instruction-for-us-figure-j (Instruction For Us Figure J)

An instructional diagram showing how to properly inject subcutaneously at a 90-degree angle. The illustration depicts a hand holding a syringe inserted into fold of skin near the abdomen area, with an arrow indicating the injection direction.*

FDA Label Image

Instruction-for-us-figure-k (Instruction For Us Figure K)

An instructional illustration showing a person administering a subcutaneous injection in the abdominal area using a syringe. One hand pinches the skin while the other hand holds the syringe angled toward the skin, with an arrow indicating the injection direction.*

FDA Label Image

Instruction-for-us-figure-l (Instruction For Us Figure L)

An instructional illustration showing a hand holding a syringe for subcutaneous injection, aimed at the abdomen area of the body, with an arrow indicating the direction of injection. This diagram likely demonstrates the proper technique for administering Enoxaparin Sodium injection subcutaneously.*

FDA Label Image

Instruction-for-us-figure-m (Instruction For Us Figure M)

An instructional illustration showing a hand holding a syringe labeled with a protective sleeve. An arrow and the word 'CLICK' indicate how to attach or engage the protective sleeve on the syringe, demonstrating part of the preparation or safety procedure for an injection device.*

FDA Label Image

Instruction-for-us-figure-n (Instruction For Us Figure N)

An instructional illustration showing a hand holding a syringe labeled 'Syringe' above a sharps disposal container labeled 'Sharps Disposal Container.' A needle cap is depicted being removed from the syringe and directed into the disposal container. The image demonstrates safe disposal of syringe needle caps into a sharps container.*

FDA Label Image

Instruction-for-us-figure (Instruction For Us Figure)

An instructional diagram illustrating the components and state of a syringe before and after use. The "Before Use" syringe is shown with a plunger rod, needle, and needle cap, while the "After Use" syringe includes a plunger rod and a protective sleeve covering the needle.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.